Walter Ling, M.D.
Excellence in Mentoring, 2010
UCLA Integrated Substance Abuse Programs
David Geffen School of Medicine
University of California Los Angeles (UCLA)
Los Angeles, California, United States
A productive researcher whose clinical trials helped pave the way for U.S. approval of naltrexone, buprenorphine, and LAAM, Walter Ling also has trained a generation of drug abuse researchers. Directing the Integrated Substance Abuse Programs at the University of California Los Angeles, Dr. Ling has helped prepare young scientists to significantly improve drug abuse research around the globe—from Australia to Europe, the Middle East, Asia, and the United States. As principal investigator for the NIDA Clinical Trials Network Pacific Region Node, Dr. Ling has trained researchers and treatment providers while conducting research on psychosocial and pharmacological treatments for opiate, cocaine, methamphetamine, alcohol, and nicotine abuse. His protégés include successful NIDA grantees and former NIDA International Program Fellows who learned more than just science from Dr. Ling: many of them have followed his example by building productive research and training centers, particularly in China and Thailand.
Important Dates
NIDA International Forum
June 14–17, 2013
Online Registration Deadline:
May 6, 2013
FELLOWSHIPS
IAS/NIDA Fellowships
Application Deadline:
February 10, 2013
NIDA International Program Fellowships
Application Deadline:
April 1, 2013
Global Health Program for Fellows and Scholars
Application Deadlines: Vary
GRANTS
Brain Disorders in the Developing World: Research Across the Lifespan
(Non-AIDS)
R01 PAR-11-030and R21 PAR-11-031
Application deadline:
February 14, 2013
MEETINGS
American Association for the Advancement of Science
February 14–18, 2013
Boston, Massachusetts, USA
International Drug Abuse Research Society (IDARS)
April 15–19, 2013
Mexico City, Mexico
2013 International Conference on Global Health: Prevention and Treatment of Substance Abuse and HIV
April 17–19, 2013
Taipei, Taiwan
Yih-Ing Hser, Ph.D.